Compare MFIN & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFIN | SCTX |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | 179 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 297.2M |
| IPO Year | N/A | 2026 |
| Metric | MFIN | SCTX |
|---|---|---|
| Price | $9.47 | $16.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $11.25 | ★ $57.00 |
| AVG Volume (30 Days) | 52.3K | ★ 346.2K |
| Earning Date | 10-29-2026 | 11-12-2026 |
| Dividend Yield | ★ 6.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.27 | N/A |
| P/E Ratio | $6.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.85 | $13.50 |
| 52 Week High | $12.26 | $39.60 |
| Indicator | MFIN | SCTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.44 | 43.27 |
| Support Level | $9.30 | $13.90 |
| Resistance Level | $10.10 | $22.07 |
| Average True Range (ATR) | 0.46 | 1.58 |
| MACD | -0.11 | 0.33 |
| Stochastic Oscillator | 15.34 | 52.49 |
Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.